SOTIO's Dendritic Cell Vaccines Have Promise In Ovary And Lung Cancer
Executive Summary
Interim Phase II data has shown that SOTIO's dendritic cell-based cancer vaccine candidates have efficacy in patients with ovarian cancer and non-small cell lung cancer.